On Jan. 15, the OIG published an Advisory Opinion regarding a program that would provide free access to a pharmaceutical product to patients who meet financial and other eligibility criteria and who do not have adequate coverage for the product.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.